Bortezomib Plus Melphalan-Prednisone Continues to Demonstrate a Survival Benefit Vs Melphalan-Prednisone in the Phase III VISTA Trial in Previously Untreated Multiple Myeloma After 3 Years' Follow-up and Extensive Subsequent Therapy Use

Mv Mateos; Pg Richardson; Peter Lautenschlager; Nk Khuageva; Ma Dimopoulos; O Shpilberg; M. Kropff; I. Spicka; Mt Petrucci; A. Palumbo; Os Samoilova; A. Dmoszynska; Km Abdulkadyrov; Henri Schots; B. Jiang; Dl Esseltine; K. Liu; A. Cakana; A. Van De Velde; Jésus F. San Miguel

Bortezomib Plus Melphalan-Prednisone Continues to Demonstrate a Survival Benefit Vs Melphalan-Prednisone in the Phase III VISTA Trial in Previously Untreated Multiple Myeloma After 3 Years' Follow-up and Extensive Subsequent Therapy Use

Mv Mateos, Pg Richardson, Peter Lautenschlager, Nk Khuageva, Ma Dimopoulos, O Shpilberg, M. Kropff, I. Spicka, Mt Petrucci, A. Palumbo, Os Samoilova, A. Dmoszynska, Km Abdulkadyrov, Henri Schots, B. Jiang, Dl Esseltine, K. Liu, A. Cakana, A. Van De Velde, Jésus F. San Miguel

Hematology

Research output: Contribution to journal › Conference paper

59 Citations (Scopus)

Abstract

abstract

Original language	English
Pages (from-to)	1484-1485
Number of pages	2
Journal	Blood
Volume	114
Issue number	22
Publication status	Published - 20 Nov 2009
Event	Finds and Results from the Swedish Cyprus Expedition: A Gender Perspective at the Medelhavsmuseet - Stockholm, Sweden Duration: 21 Sep 2009 → 25 Sep 2009

Keywords

multiple myeloma
therapy

Fingerprint

Dive into the research topics of 'Bortezomib Plus Melphalan-Prednisone Continues to Demonstrate a Survival Benefit Vs Melphalan-Prednisone in the Phase III VISTA Trial in Previously Untreated Multiple Myeloma After 3 Years' Follow-up and Extensive Subsequent Therapy Use'. Together they form a unique fingerprint.

Cite this

Mateos, M., Richardson, P., Lautenschlager, P., Khuageva, N., Dimopoulos, M., Shpilberg, O., Kropff, M., Spicka, I., Petrucci, M., Palumbo, A., Samoilova, O., Dmoszynska, A., Abdulkadyrov, K., Schots, H., Jiang, B., Esseltine, D., Liu, K., Cakana, A., Van De Velde, A., & San Miguel, J. F. (2009). Bortezomib Plus Melphalan-Prednisone Continues to Demonstrate a Survival Benefit Vs Melphalan-Prednisone in the Phase III VISTA Trial in Previously Untreated Multiple Myeloma After 3 Years' Follow-up and Extensive Subsequent Therapy Use. Blood, 114(22), 1484-1485.

Mateos, Mv ; Richardson, Pg ; Lautenschlager, Peter ; Khuageva, Nk ; Dimopoulos, Ma ; Shpilberg, O ; Kropff, M. ; Spicka, I. ; Petrucci, Mt ; Palumbo, A. ; Samoilova, Os ; Dmoszynska, A. ; Abdulkadyrov, Km ; Schots, Henri ; Jiang, B. ; Esseltine, Dl ; Liu, K. ; Cakana, A. ; Van De Velde, A. ; San Miguel, Jésus F. / Bortezomib Plus Melphalan-Prednisone Continues to Demonstrate a Survival Benefit Vs Melphalan-Prednisone in the Phase III VISTA Trial in Previously Untreated Multiple Myeloma After 3 Years' Follow-up and Extensive Subsequent Therapy Use. In: Blood. 2009 ; Vol. 114, No. 22. pp. 1484-1485.

@article{27d82cb4cab04e839e63cea5773b2575,

title = "Bortezomib Plus Melphalan-Prednisone Continues to Demonstrate a Survival Benefit Vs Melphalan-Prednisone in the Phase III VISTA Trial in Previously Untreated Multiple Myeloma After 3 Years' Follow-up and Extensive Subsequent Therapy Use",

abstract = "abstract",

keywords = "multiple myeloma, therapy",

author = "Mv Mateos and Pg Richardson and Peter Lautenschlager and Nk Khuageva and Ma Dimopoulos and O Shpilberg and M. Kropff and I. Spicka and Mt Petrucci and A. Palumbo and Os Samoilova and A. Dmoszynska and Km Abdulkadyrov and Henri Schots and B. Jiang and Dl Esseltine and K. Liu and A. Cakana and {Van De Velde}, A. and {San Miguel}, {J{\'e}sus F.}",

year = "2009",

month = nov,

day = "20",

language = "English",

volume = "114",

pages = "1484--1485",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "22",

note = "Finds and Results from the Swedish Cyprus Expedition: A Gender Perspective at the Medelhavsmuseet ; Conference date: 21-09-2009 Through 25-09-2009",

}

Mateos, M, Richardson, P, Lautenschlager, P, Khuageva, N, Dimopoulos, M, Shpilberg, O, Kropff, M, Spicka, I, Petrucci, M, Palumbo, A, Samoilova, O, Dmoszynska, A, Abdulkadyrov, K, Schots, H, Jiang, B, Esseltine, D, Liu, K, Cakana, A, Van De Velde, A & San Miguel, JF 2009, 'Bortezomib Plus Melphalan-Prednisone Continues to Demonstrate a Survival Benefit Vs Melphalan-Prednisone in the Phase III VISTA Trial in Previously Untreated Multiple Myeloma After 3 Years' Follow-up and Extensive Subsequent Therapy Use', Blood, vol. 114, no. 22, pp. 1484-1485.

Bortezomib Plus Melphalan-Prednisone Continues to Demonstrate a Survival Benefit Vs Melphalan-Prednisone in the Phase III VISTA Trial in Previously Untreated Multiple Myeloma After 3 Years' Follow-up and Extensive Subsequent Therapy Use. / Mateos, Mv; Richardson, Pg; Lautenschlager, Peter; Khuageva, Nk; Dimopoulos, Ma; Shpilberg, O; Kropff, M.; Spicka, I.; Petrucci, Mt; Palumbo, A.; Samoilova, Os; Dmoszynska, A.; Abdulkadyrov, Km; Schots, Henri; Jiang, B.; Esseltine, Dl; Liu, K.; Cakana, A.; Van De Velde, A.; San Miguel, Jésus F.

In: Blood, Vol. 114, No. 22, 20.11.2009, p. 1484-1485.

Research output: Contribution to journal › Conference paper

TY - JOUR

T1 - Bortezomib Plus Melphalan-Prednisone Continues to Demonstrate a Survival Benefit Vs Melphalan-Prednisone in the Phase III VISTA Trial in Previously Untreated Multiple Myeloma After 3 Years' Follow-up and Extensive Subsequent Therapy Use

AU - Mateos, Mv

AU - Richardson, Pg

AU - Lautenschlager, Peter

AU - Khuageva, Nk

AU - Dimopoulos, Ma

AU - Shpilberg, O

AU - Kropff, M.

AU - Spicka, I.

AU - Petrucci, Mt

AU - Palumbo, A.

AU - Samoilova, Os

AU - Dmoszynska, A.

AU - Abdulkadyrov, Km

AU - Schots, Henri

AU - Jiang, B.

AU - Esseltine, Dl

AU - Liu, K.

AU - Cakana, A.

AU - Van De Velde, A.

AU - San Miguel, Jésus F.

PY - 2009/11/20

Y1 - 2009/11/20

N2 - abstract

AB - abstract

KW - multiple myeloma

KW - therapy

M3 - Conference paper

VL - 114

SP - 1484

EP - 1485

JO - Blood

JF - Blood

SN - 0006-4971

IS - 22

T2 - Finds and Results from the Swedish Cyprus Expedition: A Gender Perspective at the Medelhavsmuseet

Y2 - 21 September 2009 through 25 September 2009

ER -